Producción científica por año
Producción científica por año
Huella digital
Profundizar en los temas de investigación en los que John Sarantopoulos está activo. Estas etiquetas de temas provienen de las obras de esta persona. Juntos, forma una huella digital única.
- 1 Perfiles similares
Colaboraciones y áreas de investigación principales de los últimos cinco años
Colaboración externa reciente a nivel de país/territorio. Para consultar los detalles, haga clic en los puntos o
-
Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer
Mahalingam, D., Hanni, S., Serritella, A. V., Fountzilas, C., Michalek, J., Hernandez, B., Sarantopoulos, J., Datta, P., Romero, O., Pillai, S. M. A., Kuhn, J., Pollak, M. & Thompson, I. M., 2023, En: Oncotarget. 14, 1, p. 622-636 15 p.Producción científica: Article › revisión exhaustiva
Acceso abierto -
A First-in-Human, Phase I, Multicenter, Open-Label, Dose-Escalation Study of PCA062: An Antibody-Drug Conjugate Targeting P-Cadherin, in Patients With Solid Tumors
Duca, M., Lim, D. W. T., Subbiah, V., Takahashi, S., Sarantopoulos, J., Varga, A., D'Alessio, J. A., Abrams, T., Sheng, Q., Tan, E. Y., Rosa, M. S., Gonzalez-Maffe, J., Sand-Dejmek, J., Fabre, C. & Martin, M., abr 2022, En: Molecular cancer therapeutics. 21, 4, p. 625-634 10 p.Producción científica: Article › revisión exhaustiva
3 Citas (Scopus) -
Antitumor Activity of Lurbinectedin, a Selective Inhibitor of Oncogene Transcription, in Patients with Relapsed Ewing Sarcoma: Results of a Basket Phase II Study
Subbiah, V., Braña, I., Longhi, A., Boni, V., Delord, J. P., Awada, A., Boudou-Rouquette, P., Sarantopoulos, J., Shapiro, G. I., Elias, A., Ratan, R., Fernandez, C., Kahatt, C., Cullell-Young, M., Siguero, M., Zeaiter, A. & Chawla, S. P., jul 1 2022, En: Clinical Cancer Research. 28, 13, p. 2762-2770 9 p.Producción científica: Article › revisión exhaustiva
Acceso abierto7 Citas (Scopus) -
ARRY-382 in Combination with Pembrolizumab in Patients with Advanced Solid Tumors: Results from a Phase 1b/2 Study
Johnson, M., Dudek, A. Z., Sukari, A., Call, J., Kunk, P. R., Lewis, K., Gainor, J. F., Sarantopoulos, J., Lee, P., Golden, A., Harney, A., Rothenberg, S. M., Zhang, Y. & Goldman, J. W., jun 15 2022, En: Clinical Cancer Research. 28, 12, p. 2517-2526 10 p.Producción científica: Article › revisión exhaustiva
Acceso abierto5 Citas (Scopus) -
Modulation of autophagy: a Phase II study of vorinostat plus hydroxychloroquine versus regorafenib in chemotherapy-refractory metastatic colorectal cancer (mCRC)
Arora, S. P., Tenner, L. L., Sarantopoulos, J., Morris, J., Liu, Q., Mendez, J. A., Curiel, T. J., Michalek, J. & Mahalingam, D., oct 5 2022, En: British Journal of Cancer. 127, 6, p. 1153-1161 9 p.Producción científica: Article › revisión exhaustiva
4 Citas (Scopus)
Conjuntos de datos
-
Pharmacokinetics of carfilzomib in patients with advanced malignancies and varying degrees of hepatic impairment: an open-label, single-arm, phase 1 study
Brown, J. (Creator), Plummer, R. (Creator), Bauer, T. M. (Creator), Anthony, S. (Creator), Sarantopoulos, J. (Creator), Vos, F. (Creator), White, M. (Creator), Schupp, M. (Creator), Ou, Y. (Creator) & Vaishampayan, U. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3895900, https://figshare.com/collections/Pharmacokinetics_of_carfilzomib_in_patients_with_advanced_malignancies_and_varying_degrees_of_hepatic_impairment_an_open-label_single-arm_phase_1_study/3895900
Dataset
-
Phase 1 study of M2698, a p70S6K/AKT dual inhibitor, in patients with advanced cancer
Tsimberidou, A. (Creator), Shaw, J. V. (Creator), Juric, D. (Creator), Verschraegen, C. (Creator), Weise, A. M. (Creator), Sarantopoulos, J. (Creator), Lopes, G. (Creator), Nemunaitis, J. (Creator), Mita, M. (Creator), Park, H. (Creator), Ellers-Lenz, B. (Creator), Tian, H. (Creator), Xiong, W. (Creator), Kaleta, R. (Creator) & Kurzrock, R. (Creator), Figshare, 2021
DOI: 10.6084/m9.figshare.c.5568537.v1, https://springernature.figshare.com/collections/Phase_1_study_of_M2698_a_p70S6K_AKT_dual_inhibitor_in_patients_with_advanced_cancer/5568537/1
Dataset
-
Phase 1 study of M2698, a p70S6K/AKT dual inhibitor, in patients with advanced cancer
Tsimberidou, A. (Creator), Shaw, J. V. (Creator), Juric, D. (Creator), Verschraegen, C. (Creator), Weise, A. M. (Creator), Sarantopoulos, J. (Creator), Lopes, G. (Creator), Nemunaitis, J. (Creator), Mita, M. (Creator), Park, H. (Creator), Ellers-Lenz, B. (Creator), Tian, H. (Creator), Xiong, W. (Creator), Kaleta, R. (Creator) & Kurzrock, R. (Creator), Figshare, 2021
DOI: 10.6084/m9.figshare.c.5568537, https://springernature.figshare.com/collections/Phase_1_study_of_M2698_a_p70S6K_AKT_dual_inhibitor_in_patients_with_advanced_cancer/5568537
Dataset
-
Pharmacokinetics of carfilzomib in patients with advanced malignancies and varying degrees of hepatic impairment: an open-label, single-arm, phase 1 study
Brown, J. (Creator), Plummer, R. (Creator), Bauer, T. M. (Creator), Anthony, S. (Creator), Sarantopoulos, J. (Creator), Vos, F. (Creator), White, M. (Creator), Schupp, M. (Creator), Ou, Y. (Creator) & Vaishampayan, U. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3895900.v1, https://figshare.com/collections/Pharmacokinetics_of_carfilzomib_in_patients_with_advanced_malignancies_and_varying_degrees_of_hepatic_impairment_an_open-label_single-arm_phase_1_study/3895900/1
Dataset